UnitedHealth Group is set to report second-quarter 2026 earnings on July 16 before the market opens, with analysts expecting adjusted earnings per share of $4.84–$4.85, reflecting 18.6% year-over-year growth from $4.08in the same period last year.
The health insurer will host a conference call at 8 a.m. ET to discuss results. Analysts expect revenue of approximately $111.9 billion for the quarter, according to consensus forecasts tracked by multiple financial data providers.
The expected EPS growth marks a sharp rebound from UnitedHealth’s troubled 2025, when the company faced mounting medical costs and operational challenges. In January 2026, the company issued a cautious full-year outlook, forecasting revenue of greater than $439 billion—a potential decline from 2025’s $447.6 billion. However, the company’s Q1 2026 performance shifted the narrative significantly.
UnitedHealth delivered a strong Q1 2026 earnings beat in April, reporting adjusted EPS of $7.23 against consensus estimates of $6.59–$6.76, exceeding expectations by roughly 10%. The company simultaneously raised its full-year 2026 adjusted EPS guidance to greater than $18.25, up 50 cents from the prior forecast of greater than $17.75, signaling confidence in a recovery trajectory.
Wall Street has taken notice. Among 26 analysts covering UNH stock, the consensus rating stands at “Buy” or “Strong Buy,” according to Yahoo Finance and MarketBeat. Polymarket traders currently assign a 71% probability that UnitedHealth will beat Q2 earnings expectations, suggesting broad optimism heading into the report.
The Q2 earnings will test whether UnitedHealth can sustain the momentum from Q1. Medical cost inflation, which pressured margins throughout 2025, remains a focal point for investors. The company has been working to right-size its Medicare Advantage portfolio and manage medical loss ratios after a difficult year. Success in controlling costs while growing revenue will be critical to validating the raised full-year guidance.
Sources
- Yahoo Finance — Q2 2026 EPS expectation of $4.84, up 18.6% year-over-year from $4.08
- Barchart.com — Q2 2026 EPS forecast of $4.84, up 18.6% from prior-year quarter; full-year 2026 EPS projection of $18.32
- UnitedHealth Group (official) — Announcement that Q2 2026 earnings release scheduled for July 16, 2026, before market open, with 8 a.m. ET earnings call
- CNBC — Q1 2026 adjusted EPS of $7.23 versus $6.57 expected; revenue of $111.72 billion versus $109.57 billion expected
- Reuters — Full-year 2026 adjusted EPS guidance raised to greater than $18.25, up from prior forecast of greater than $17.75
- TIKR.com — Q1 2026 adjusted EPS of $7.23 and raised full-year guidance of greater than $18.25 indicating recovery ahead of plan
- AOL/Motley Fool — Polymarket traders assign 71% probability of Q2 earnings beat
- MarketBeat — Analyst consensus rating and coverage breakdown for UNH stock
